Cystic Fibrosis phenylalanine 508 mutation

Cat no. YSL-SNP-CFTR-100

Cystic Fibrosis phenylalanine 508 mutation

Cat no. YSL-SNP-CFTR-100

A qPCR genotyping kit for Cystic Fibrosis phenylalanine 508 mutation

Cystic Fibrosis Phenylalanine 508 Mutation is a genetic mutation predominantly found in the human population, leading to the production of a faulty CFTR protein that affects the flow of salt and water into and out of cells. This can result in the build-up of thick, sticky mucus in the lungs and other organs, causing respiratory issues and digestive problems. It is crucial to detect this mutation early to provide timely intervention and management for individuals with cystic fibrosis, especially in the healthcare sector.

YouSeq's qPCR kit to detect Cystic Fibrosis Phenylalanine 508 Mutation allows for sensitive and specific identification of this genetic mutation, enabling early diagnosis and personalized treatment plans for affected individuals. Rapid detection of this target can lead to improved clinical outcomes, better disease management, and enhanced quality of life for patients with cystic fibrosis.

United States FlagAvailable for delivery in United States

Price on enquiry

Order now

For Research Use Only. Not intended for diagnostic use.

Contents


Target Specific primer/probe
qPCR MasterMix
2 x Positive control template
DNase/RNase free water
Template resuspension buffer
ROX Passive Reference

Technical specification


Sensitivity: 100 copy detection
Run Time: Approx 1hr30 (dependent on instrumentation)
Detection Channels: FAM & VIC/HEX labelled

Product variants


YSL-SNP-CFTR-100 : Lyophilised version for ambient shipping
YS-SNP-CFTR-100 : Frozen version for dry ice shipping

Pseudonyms

CFTR mutation; CF; Cystic fibrosis; ?F508; Cystic fibrosis transmembrane conductance regulator mutation; Mucoviscidosis; 508 mutation

Related products

More products

Still scrolling? We love adventurers

We work at the cutting edge of molecular biology, striving to disrupt our industry. We drive continuous product innovation and we aren’t afraid to take on new challenges.

More about us

Related learning resources